Valuation Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.23 CNY | -1.06% |
|
-1.49% | -15.25% |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025 | CI |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director | CI |
Company Valuation: Aier Eye Hospital Group Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 308,658 | 228,569 | 222,975 | 147,575 | 123,187 | 104,390 | - | - |
| Change | - | -25.95% | -2.45% | -33.82% | -16.53% | -15.26% | - | - |
| Enterprise Value (EV) 1 | 307,677 | 226,545 | 218,198 | 143,117 | 120,082 | 100,006 | 96,760 | 94,320 |
| Change | - | -26.37% | -3.68% | -34.41% | -16.1% | -16.72% | -3.25% | -2.52% |
| P/E ratio | 177x | 97.6x | 85.1x | 43.6x | 34.4x | 29x | 24.4x | 20.8x |
| PBR | 31.3x | 20.2x | 13.4x | 7.83x | 5.97x | 4.58x | 3.99x | 3.55x |
| PEG | - | 3x | 9.07x | 1.5x | 5.78x | 39.01x | 1.3x | 1.2x |
| Capitalization / Revenue | 25.9x | 15.2x | 13.8x | 7.25x | 5.87x | 4.64x | 4.13x | 3.68x |
| EV / Revenue | 25.8x | 15.1x | 13.5x | 7.03x | 5.72x | 4.45x | 3.82x | 3.33x |
| EV / EBITDA | 95.4x | 54.5x | - | 24x | 17.2x | 15.4x | 13.3x | 11.5x |
| EV / EBIT | 115x | 64.8x | 61.7x | 28.9x | 24.9x | 20.1x | 16.7x | 14.1x |
| EV / FCF | 125x | 87.3x | 70.2x | 32.4x | 39.3x | 33.3x | 22.7x | 18.1x |
| FCF Yield | 0.8% | 1.15% | 1.43% | 3.09% | 2.55% | 3% | 4.41% | 5.54% |
| Dividend per Share 2 | 0.0685 | 0.071 | 0.0769 | 0.15 | 0.16 | 0.1632 | 0.1968 | 0.2331 |
| Rate of return | 0.2% | 0.28% | 0.32% | 0.95% | 1.21% | 1.45% | 1.75% | 2.08% |
| EPS 2 | 0.1932 | 0.2566 | 0.2807 | 0.3631 | 0.3847 | 0.3876 | 0.4608 | 0.5391 |
| Distribution rate | 35.5% | 27.7% | 27.4% | 41.3% | 41.6% | 42.1% | 42.7% | 43.2% |
| Net sales 1 | 11,912 | 15,001 | 16,110 | 20,367 | 20,983 | 22,492 | 25,299 | 28,354 |
| EBITDA 1 | 3,225 | 4,156 | - | 5,954 | 6,986 | 6,475 | 7,293 | 8,177 |
| EBIT 1 | 2,674 | 3,494 | 3,534 | 4,948 | 4,825 | 4,964 | 5,807 | 6,668 |
| Net income 1 | 1,724 | 2,323 | 2,524 | 3,359 | 3,556 | 3,593 | 4,246 | 4,934 |
| Net Debt 1 | -980.9 | -2,024 | -4,777 | -4,458 | -3,105 | -4,384 | -7,630 | -10,070 |
| Reference price 2 | 34.20 | 25.03 | 23.90 | 15.82 | 13.25 | 11.23 | 11.23 | 11.23 |
| Nbr of stocks (in thousands) | 9,025,341 | 9,130,452 | 9,329,492 | 9,328,411 | 9,297,140 | 9,295,651 | - | - |
| Announcement Date | 4/22/21 | 4/25/22 | 4/25/23 | 4/25/24 | 4/24/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 28.98x | 4.45x | 15.45x | 1.45% | 14.76B | ||
| 37.77x | 3.33x | 14.85x | 1.22% | 17.86B | ||
| 55.04x | 4.3x | 29.24x | 0.3% | 11.53B | ||
| 21.01x | 2.32x | 11.05x | 0.64% | 11.37B | ||
| 30.24x | 2.34x | 19.95x | 0.14% | 10.23B | ||
| 18.12x | 2.71x | 10.98x | 4.04% | 9.33B | ||
| 15.5x | 1.33x | 9.15x | 1.19% | 8.11B | ||
| 58.76x | 7.45x | 31.96x | 0.15% | 7.47B | ||
| 27.33x | 0.84x | 6.96x | 2.34% | 5.65B | ||
| 41.04x | 5.37x | 25.68x | 0.26% | 4.38B | ||
| Average | 33.38x | 3.44x | 17.53x | 1.17% | 10.07B | |
| Weighted average by Cap. | 33.30x | 3.43x | 17.15x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 300015 Stock
- Valuation Aier Eye Hospital Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















